Breast CAncer

Most Patients With Breast, Ovarian Cancer Patients Do Not Undergo Genetic Testing

By

Christina Bennett, MS

Publish Date March 2, 2021

The number of genes tested for ovarian and breast cancer has grown, but most patients do not undergo testing, and variant-of-unknown-significance results are common, especially among minority populations.

Inverse Relationship Between Sun Exposure, Risk for Late Onset Breast Cancer

By

Bette Weinstein Kaplan

Publish Date February 26, 2021

A team of Danish researchers investigate the relationship between work-related direct UVR exposure and risk for breast cancer in women older than 50.

Protein-Truncating and Rare Missense Variants Associated With Risk for Breast Cancer

By

Jessica Nye, PhD

Publish Date February 19, 2021

Researchers identified the genes that may allow for a better prediction of risk for breast cancer.

Estradiol Challenge Test ‘Highly Predictive’ of Response to Endocrine Therapy in Patients With ER-Positive Breast Cancer

By

Leah Lawrence

Publish Date February 17, 2021

Investigators measured responses to endocrine therapy by monitoring the change in tumor uptake of the progestin analog 21-[18F] fluorofuranylnorprogesterone (FFNP) before and after a 1-day estradiol challenge.

Gonadotropin-Releasing Hormone Analogue Worsens Treatment-Related Adverse Effects in Male Breast Cancer

By

Jessica Nye, PhD

Publish Date February 10, 2021

Researchers sought to determine the effects of dual therapy of aromatase inhibitor or tamoxifen with GnRHa in men with breast cancer.

Female Breast Cancer Most Commonly Diagnosed Cancer in 2020

Publish Date February 5, 2021

Female breast cancer surpassed lung cancer, although lung cancer remained leading cause of cancer deaths in 2020.

American Cancer Society 2021 Statistics Report Shows Continuous Decline in Cancer Mortality Rate, Illuminates Disease-Specific Trends

By

Rachel Narozniak, MA

Publish Date February 4, 2021

The American Cancer Society’s annual report approximates the new cancer diagnoses and deaths expected in 2021 and identifies impactful patterns in oncology care.

New Validated Risk Score Predicts Chemotherapy Toxicity in Older Patients With Breast Cancer

By

Jessica Nye, PhD

Publish Date January 28, 2021

The CARG-BC risk score was developed to accurately and specifically stratify risk of chemotherapy toxicity in patients 65 and older with early-stage breast cancer.

Tool Can Predict Chemo Toxicity for Seniors With Breast Cancer

Publish Date January 21, 2021

Score has been developed and validated that includes eight independent predictors of grade 3 to 5 chemotherapy toxicity.

Financial Toxicity Linked to QOL After Breast Cancer Surgery

Publish Date January 14, 2021

Strongest correlation seen for BREAST-Q psychosocial well-being, with 0.89 change per unit change in financial toxicity score.